SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-17-177838
Filing Date
2017-05-22
Accepted
2017-05-22 13:59:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d401796dsc13g.htm SC 13G 41603
  Complete submission text file 0001193125-17-177838.txt   43190
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Subject) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88334 | Film No.: 17860480
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6 YONI NETANYAHU ST OR-YEHUDA L3 6037604
Business Address 6 YONI NETANYAHU ST OR-YEHUDA L3 6037604 972-3-3634990
Peregrine Ventures Management Ltd. (Filed by) CIK: 0001706369 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G